Re: statistical and clinical significance Thank you @DoctorBrad...

First 218 Last

Share
Profile

Follow
betheball

1,194 Posts.

119

26/07/20

10:38

Post #: 46070065
Share

Originally posted by DoctorBrad: ↑

There’s been some mention about statistical and clinical significance, especially regarding the FSGS study with ten patients. We would be looking for clinical, not statistical significance from the FSGS study.

One doesn’t need to look too far for comparison.

RAC recently released results for their repurposed drug, BISANTRENE.
In mid-June, with a share price of 31.5¢, they released results stating a 40% positive clinical response rate in their malignancy of choice. One patient went into complete remission, and three others achieved partial remission. (Of note, no patients dropped out, but I still can’t find out what happened to the other six....)
There was no mention of statistical significance, the patient sample was too small, but they did claim clinical significance. And in refractory malignancy, any positive cases should be shouted from the rooftops! Who is to know if the one who went into complete remission wasn’t going to do that anyway? Maybe her brand of holy water was better than anyone else’s?
They opened mid-50s, and have progressed up to around $1/share. Peaking at $1.17
Now RAC has 122M SOI, and the market they’re seeking is very large, but BISANTRENE would be used as an adjunct. It would not be stand-alone. Im thinking they’ll be bought out very soon.

Disc: I do not own RAC shares...despite being tipped them around 5¢ last year. I sought the advice of an oncologist-friend, who told me that because BISANTRENE wasn’t a biologic, that it probably wouldn’t fly... My gut said invest, it ticked all my biotech boxes, but I went with a clinical expert in the field... much to my disappointment.

TH tomorrow morning, I reckon.

Expand

Re: statistical and clinical significance
Thank you @DoctorBrad
That has helped me with my previous question.
cheers

DXB Price at posting: 38.0¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

CC9

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

FEX

From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources

AL8

From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources

SXG

From the Floor question: "Could gold be manufactured in a lab like diamonds?"

Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars

There are more pages in this discussion • 1 more message in this thread...

First 218 Last

Add DXB (ASX) to my watchlist

(20min delay)
Last 55.5¢		Change -0.015(2.63%)		Mkt cap ! $305.1M

Open	High	Low	Value	Volume
56.0¢	58.5¢	54.0¢	$3.231M	5.779M

Buyers (Bids)

No.	Vol.	Price($)
1	1118	55.5¢

Sellers (Offers)

Price($)	Vol.	No.
56.5¢	239062	1

View Market Depth

No.	Vol.	Price($)
1	1118	0.555
3	56053	0.550
6	111652	0.545
15	259396	0.540
4	69275	0.535

Price($)	Vol.	No.
0.565	239062	1
0.570	95670	3
0.575	33246	2
0.580	11000	1
0.585	74555	5

Last trade - 16.10pm 19/06/2024 (20 minute delay)

DXB (ASX) Chart

Re: statistical and clinical significance Thank you @DoctorBrad...

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources

From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources

From the Floor question: "Could gold be manufactured in a lab like diamonds?"

Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Re: statistical and clinical significance Thank you @DoctorBrad...

Top Stories

The USA's dominance requires a domestic lithium supply chain. Chariot stands to benefit

From the Floor question: "When will FEX start using rail to augment & de-risk their haulage solution?" | Fenix Resources

From the Floor question: "What is the focus of AL8 and how is management going to attract shareholders to the registry?" | Alderan Resources

From the Floor question: "Could gold be manufactured in a lab like diamonds?"

Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News